Eikon Therapeutics Ord Shs
EIKN9.810USD
-0.720-6.84%
Close 03/27, 16:00（ET）Quotes delayed by 15 min
529.59MMarket Cap
--P/E TTM
More Details of Eikon Therapeutics Ord Shs Company
Eikon Therapeutics Ord Shs Info
Ticker SymbolEIKN
Company nameEikon Therapeutics Inc
IPO dateFeb 05, 2026
CEOPerlmutter (Roger M)
Number of employees384
Security typeOrdinary Share
Fiscal year-endFeb 05
Address230 Harriet Tubman Way
CityMILLBRAE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94030
Phone13026587581
Websitehttps://eikontx.com/
Ticker SymbolEIKN
IPO dateFeb 05, 2026
CEOPerlmutter (Roger M)
Company Executives of Eikon Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
2.00
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
1.00
--
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
Dr. Leon Chen, Ph.D.
Dr. Leon Chen, Ph.D.
Director
Director
--
--
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
2.00
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
1.00
--
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Feb 20
Updated: Fri, Feb 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lux Capital Management, LLC
10.55%
Foresite Capital Management, LLC
7.68%
The Column Group LP
7.20%
Innovation Endeavors III, L.P.
5.73%
Abu Dhabi Investment Authority
5.22%
Other
63.62%
Shareholders
Shareholders
Proportion
Lux Capital Management, LLC
10.55%
Foresite Capital Management, LLC
7.68%
The Column Group LP
7.20%
Innovation Endeavors III, L.P.
5.73%
Abu Dhabi Investment Authority
5.22%
Other
63.62%
Shareholder Types
Shareholders
Proportion
Venture Capital
17.75%
Corporation
11.99%
Private Equity
7.68%
Sovereign Wealth Fund
5.22%
Individual Investor
2.83%
Other
54.52%
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
